Christopher Viereck

1.4k total citations
14 papers, 440 citations indexed

About

Christopher Viereck is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Christopher Viereck has authored 14 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Christopher Viereck's work include Glycogen Storage Diseases and Myoclonus (2 papers), Pharmacology and Obesity Treatment (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Christopher Viereck is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (2 papers), Pharmacology and Obesity Treatment (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Christopher Viereck collaborates with scholars based in United States, Switzerland and United Kingdom. Christopher Viereck's co-authors include Andrew Matus, LI Binder, Richard P. Tucker, Lester I. Binder, Pol Boudes, Dominique P. Germain, Nina Skuban, Kathy Nicholls, Jay Barth and Jeffrey P. Castelli and has published in prestigious journals such as Journal of Neuroscience, Biological Psychiatry and Brain Research.

In The Last Decade

Christopher Viereck

14 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Viereck United States 7 201 178 120 114 98 14 440
Jingjing Wu United States 8 144 0.7× 118 0.7× 115 1.0× 102 0.9× 19 0.2× 13 365
Trisha R. Stankiewicz United States 8 88 0.4× 347 1.9× 136 1.1× 69 0.6× 42 0.4× 9 548
Glee Yorke United States 7 141 0.7× 438 2.5× 180 1.5× 93 0.8× 43 0.4× 12 595
Letizia Marvaldi Israel 9 55 0.3× 257 1.4× 146 1.2× 76 0.7× 46 0.5× 15 405
Alexandra I. Rosa Portugal 10 52 0.3× 244 1.4× 80 0.7× 64 0.6× 67 0.7× 16 473
Lucas J. Sosa Argentina 11 186 0.9× 297 1.7× 255 2.1× 113 1.0× 99 1.0× 17 582
Benjamin Dombert Germany 13 70 0.3× 288 1.6× 117 1.0× 84 0.7× 19 0.2× 15 479
Deborah A. C. Otero United States 11 66 0.3× 204 1.1× 152 1.3× 206 1.8× 53 0.5× 13 417
Yoko Kishida Japan 9 43 0.2× 311 1.7× 229 1.9× 62 0.5× 22 0.2× 11 498
Junko Sakiyama Japan 7 62 0.3× 119 0.7× 80 0.7× 23 0.2× 25 0.3× 12 374

Countries citing papers authored by Christopher Viereck

Since Specialization
Citations

This map shows the geographic impact of Christopher Viereck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Viereck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Viereck more than expected).

Fields of papers citing papers by Christopher Viereck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Viereck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Viereck. The network helps show where Christopher Viereck may publish in the future.

Co-authorship network of co-authors of Christopher Viereck

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Viereck. A scholar is included among the top collaborators of Christopher Viereck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Viereck. Christopher Viereck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Paller, Amy S., Roberta De Nardi, Hung Do, et al.. (2017). 701 Investigation of the absorption of allantoin in vitro skin models to support wound healing. Journal of Investigative Dermatology. 137(5). S120–S120. 1 indexed citations
3.
Germain, Dominique P., Roberto Giugliani, Daniel G. Bichet, et al.. (2017). Efficacy of migalastat in a cohort of male patients with the classic Fabry phenotype in the FACETS phase 3 study. Molecular Genetics and Metabolism. 120(1-2). S52–S52. 2 indexed citations
4.
Hughes, Derralynn, Kathy Nicholls, Dominique P. Germain, et al.. (2017). Response of patients with Fabry disease with the amenable GLA mutation p.N215S to treatment with migalastat. Molecular Genetics and Metabolism. 120(1-2). S68–S69. 1 indexed citations
5.
Viereck, Christopher & Pol Boudes. (2011). An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development. Contemporary Clinical Trials. 32(3). 324–332. 14 indexed citations
6.
Viereck, Christopher & Pol Boudes. (2009). An analysis of current pharmaceutical industry practices for making clinical trial results publicly accessible. Contemporary Clinical Trials. 30(4). 293–299. 2 indexed citations
7.
Austin, Matthew, et al.. (2000). Long-term treatment of type 2 diabetes mellitus with glimepiride is weight neutral: A meta-analysis. Diabetes Research and Clinical Practice. 50. 47–47. 15 indexed citations
8.
Sramek, John J., et al.. (1995). A “bridging” (safety/tolerance) study of Besipirdine Hydrochloride in patients with Alzheimer's disease. Life Sciences. 57(12). 1241–1248. 6 indexed citations
9.
Cutler, N.R., et al.. (1995). Tolerability and pharmacodynamics of besipirdine in Alzheimer's disease. Biological Psychiatry. 37(9). 643–643. 1 indexed citations
10.
Viereck, Christopher & Andrew Matus. (1990). The expression of phosphorylated and non-phosphorylated forms of MAP5 in the amphibian CNS. Brain Research. 508(2). 257–264. 33 indexed citations
11.
Viereck, Christopher, et al.. (1989). The adult rat olfactory system expresses microtubule-associated proteins found in the developing brain. Journal of Neuroscience. 9(10). 3547–3557. 154 indexed citations
12.
Viereck, Christopher, Richard P. Tucker, Lester I. Binder, & Andrew Matus. (1988). Phylogenetic conservation of brain microtubule-associated proteins MAP2 and TAU. Neuroscience. 26(3). 893–904. 48 indexed citations
13.
Tucker, Richard P., Christopher Viereck, & Andrew Matus. (1988). The ontogeny and phylogenetic conservation of MAP 2 forms. PROTOPLASMA. 145(2-3). 195–199. 1 indexed citations
14.
Binder, LI, et al.. (1988). The sequential appearance of low- and high-molecular-weight forms of MAP2 in the developing cerebellum. Journal of Neuroscience. 8(12). 4503–4512. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingjing Wu Breakdown of academic impact, for papers by Trisha R. Stankiewicz Breakdown of academic impact, for papers by Glee Yorke Breakdown of academic impact, for papers by Letizia Marvaldi Breakdown of academic impact, for papers by Alexandra I. Rosa Breakdown of academic impact, for papers by Lucas J. Sosa Breakdown of academic impact, for papers by Benjamin Dombert Breakdown of academic impact, for papers by Deborah A. C. Otero Breakdown of academic impact, for papers by Yoko Kishida Breakdown of academic impact, for papers by Junko Sakiyama
Rankless by CCL
2026